MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$78,605,000
Free Cash flow
$85,676,000
Unit: Dollar
Positive Cash Flow Breakdown
Increase (decrease) in accrued e...
Net income
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Increase in inventory
Decrease in account receivables
Repurchase of common stock
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
25,988,000
38,601,000
14,020,141
108,562,980
Stock-based compensation
4,084,000
4,582,000
3,589,024
4,065,541
Change in right-of-use assets
-
-
255,616
103,339
Depreciation
-
-
294,096
161,917
Amortization of intangible
-
-
10,139,555
3,628,549
Depreciation and amortization
10,540,000
10,544,000
-
-
Change in contingent consideration
-6,652,000
-4,199,000
-4,101,000
-2,400,000
Change in fair value of marketable securities
-2,546,000
3,546,000
-2,273,091
-3,090,909
Deferred income taxes
3,975,000
12,964,000
33,889,802
-59,686,802
Amortization of debt finance costs
-
-
398,000
-
Other
-729,000
-672,000
111,230
-363,230
Gain on liquidation of foreign entity
-
-
86,000
-
Decrease in account receivables
6,432,000
-16,445,000
12,395,714
87,270,234
Increase in inventory
7,852,000
1,015,000
800,120
642,977
Increase in prepaid expenses and other assets
5,093,000
2,257,000
1,363,757
-1,108,444
Increase in accounts payable
-2,776,000
4,943,000
-7,265,271
6,499,113
Increase (decrease) in accrued expenses and other liabilities
58,968,000
-50,622,000
52,279,697
54,730,977
Decrease in operating lease liabilities
-
-
-149,567
-76,666
Payment of contingent consideration liabilities
0
220,000
61,000
-
Net cash provided by operating activities
86,237,000
42,382,000
94,461,181
30,856,502
Acquisitions of businesses, net of cash acquired
-
-
-1,490,965
310,001,965
Investment in equity securities
-
-
0
5,000,000
Purchase of short-term investments
0
0
73,935
9,605,591
Maturity of short-term investments
0
3,694,000
3,600,113
33,792,887
Purchase of property, plant, and equipment and manufacturing qualification costs
561,000
729,000
1,720,104
505,774
Net cash provided by (used in) investing activities
-561,000
2,965,000
3,297,039
-291,320,443
Proceeds from sale of common stock from public offering, net
0
-
-600
3,891
Proceeds from senior convertible notes
-
-
0
150,000,000
Proceeds from sale of common stock from at-the-market program, net
0
0
1,026,427
0
Repurchase of common stock
6,392,000
11,092,000
-
-
Payment of employee withholding taxes on vested restricted stock units
131,000
1,527,000
257,440
464,088
Proceeds from exercise of stock options
235,000
1,179,000
3,592,986
1,322,690
Payment of debt issuance costs associated with the convertible notes
-
-
5,446,623
282,377
Payment of contingent consideration liabilities
606,000
522,000
189,000
-
Rou financing lease fees
177,000
135,000
138,808
49,192
Net cash (used in) provided by financing activities
-7,071,000
-12,097,000
-1,413,058
150,530,924
Foreign exchange effect on cash
0
-1,333
-
276
Net increase in cash and cash equivalents
78,605,000
33,250,000
96,343,829
-109,932,741
Cash, cash equivalents and restricted cash - beginning of period
179,075,000
145,825,000
49,481,309
40,756,138
Cash, cash equivalents and restricted cash - end of period
257,680,000
179,075,000
145,825,000
49,481,309
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Increase (decrease) in
accrued expenses and...
$58,968,000
(1045.05%↑ Y/Y)
Net income
$25,988,000
(-35.79%↓ Y/Y)
Depreciation and
amortization
$10,540,000
Change in contingent
consideration
-$6,652,000
Stock-based compensation
$4,084,000
(-33.89%↓ Y/Y)
Deferred income taxes
$3,975,000
Other
-$729,000
Net cash provided by
operating activities
$86,237,000
(73.42%↑ Y/Y)
Canceled cashflow
$24,699,000
Net increase in cash
and cash...
$78,605,000
(-33.75%↓ Y/Y)
Canceled cashflow
$7,632,000
Increase in inventory
$7,852,000
(285.87%↑ Y/Y)
Decrease in account
receivables
$6,432,000
(173.58%↑ Y/Y)
Increase in prepaid
expenses and other assets
$5,093,000
(182.05%↑ Y/Y)
Increase in accounts
payable
-$2,776,000
(-167.79%↓ Y/Y)
Change in fair value of
marketable securities
-$2,546,000
Proceeds from exercise of
stock options
$235,000
(-84.05%↓ Y/Y)
Net cash (used in)
provided by financing...
-$7,071,000
(-107.92%↓ Y/Y)
Net cash provided by
(used in) investing...
-$561,000
(97.25%↑ Y/Y)
Canceled cashflow
$235,000
Repurchase of common stock
$6,392,000
Payment of contingent
consideration liabilities
$606,000
Rou financing lease
fees
$177,000
Purchase of property,
plant, and equipment...
$561,000
(1544.10%↑ Y/Y)
Payment of employee
withholding taxes on vested...
$131,000
(-89.66%↓ Y/Y)
Buy us a coffee
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)